Investors

investor people image

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Osiris Therapeutics to Present at 2016 Cell & Gene Meeting on the Mesa View HTML
Toggle Summary Osiris Provides Update Regarding NASDAQ Listing Status
Company to Request NASDAQ Hearings Panel to Stay NASDAQ Delisting
View HTML
Toggle Summary Osiris Provides Update Regarding NASDAQ Listing Matters View HTML
Toggle Summary Grafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal View HTML
Toggle Summary Osiris Provides Update Regarding NASDAQ Listing Matters View HTML
Toggle Summary Osiris to Present at the 26th European Wound Management Association Conference View HTML
Toggle Summary Grafix Demonstrates Superior Clinical Outcomes Compared with EpiFix in "Real World" Study View HTML
Toggle Summary Osiris to Present 15 Advanced Clinical and Scientific Abstracts View HTML
Toggle Summary Osiris Announces Further Expansion of Grafix Commercial Coverage View HTML
Toggle Summary Osiris Therapeutics Announces Receipt of Deficiency Letter from NASDAQ View HTML